US FDA authorizes Moderna Covid-19 vaccine mRNA-1273
Moderna Covid-19 vaccine : The US Food and Drug Administration (FDA) has given emergency use authorization (EUA) for mRNA-1273, the messenger RNA (mRNA) Covid-19 vaccine candidate of Moderna. The FDA authorization is for the use of mRNA-1273 in individuals aged 18 years and more for the prevention of Covid-19 caused by severe acute respiratory syndrome […]
COVID-19 vaccine trials : Research Centers of America begins enrollment of healthy volunteers
August 4, 2020 No Comment
Research Centers of America (RCA), an independent research site in Broward County, Florida, said that it is currently holding COVID-19 vaccine trials, implemented under the US government’s Operation Warp Speed (OWS). The research site is enrolling volunteers to take part in the clinical trials, working with the US government and various pharma companies, which have developed […]
Continue reading …
Moderna and Laboratorios Farmacéuticos Rovi have entered into a collaboration for large-scale, commercial fill-finish manufacturing of mRNA-1273, the former’s mRNA vaccine candidate against COVID-19, at the latter’s facility in Madrid, Spain. Under the agreement terms, ROVI will offer vial filling and packaging capacity by procuring a new production line and equipment for compounding, filling, automatic […]
Continue reading …
Moderna said that it has concluded enrollment for the two cohorts of the phase 2 study of its COVID-19 vaccine candidate mRNA-1273. According to the US biotech company, mRNA-1273 is its second messenger RNA (mRNA) vaccine for an infectious disease to have wrapped up enrollment of a phase 2 clinical trial, after its CMV Phase 2 […]
Continue reading …
Moderna said that mRNA-1273, its novel coronavirus vaccine candidate, has delivered positive interim data in a phase 1 clinical trial by eliciting neutralizing antibody titer levels in all eight initial participants across the 25 µg and 100 µg dose cohorts. The early-stage clinical trial in humans was led by the US National Institute of Allergy […]
Continue reading …Coronavirus vaccine trial : Moderna doses first subject with mRNA-1273 in phase 1 trial
March 17, 2020 No Comment
Coronavirus vaccine trial : US biotech company Moderna has dosed the first participant in the phase 1 study of mRNA-1273, its mRNA vaccine against the novel coronavirus (SARS-CoV-2). The phase 1 coronavirus clinical trial is being carried out under its own Investigational New Drug (IND) application by the National Institutes of Health (NIH). mRNA-1273 is […]
Continue reading …
Business News Today
- EBRD, and others launch construction on wastewater pipeline in Amman
- Bureau Veritas acquires Canadian food auditing business of Orion Assessment Services
- Fedeli Group acquires Medicare-focused KAZ Company
- TCS rolls out curated version of Cloud Assurance Platform services for Microsoft Azure
- ICICI Bank launches InstaFX app for authorized money changers
- Bank Audi sal to sell Egyptian subsidiary to First Abu Dhabi Bank
- SEBI approves Reliance Industries acquisition of Big Bazaar and other businesses of Future Group
- Royal Caribbean Group to sell Azamara cruise brand to Sycamore Partners for $201m
- ONGC distributes solar chulhas in Betul district, Madhya Pradesh
- Citi merges wealth management units to create Citi Global Wealth
